Amizyme-Andna Test Kit
510(k) K842533
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK842533 | Date20 Sep 1984 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LJM
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.5100
- Advisory Committee
- Immunology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Amizyme Andna Test Kit is an Antinuclear Antibody (Enzyme-Labeled) Test System, classified under the Immunology specialty. It is designed for the qualitative detection of antinuclear antibodies (ANA) in serum or plasma samples, aiding in the diagnosis of autoimmune diseases such as systemic lupus erythematosus (SLE) and other connective tissue disorders. The kit employs enzyme-labeled antigens to facilitate the identification of ANA through a colorimetric reaction, providing a measurable result for clinical interpretation.
This test kit is supplied as a single-use diagnostic reagent and is intended for use in clinical laboratory settings by trained personnel. It is regulated under FDA 510(k) clearance (K842533) and falls under Device Class II (866.5100). The kit includes antigens, controls, and necessary reagents, with no indication of sterility requirements beyond standard laboratory handling. Storage conditions and shelf life are not specified in the regulatory data, but compliance with manufacturer instructions is required for optimal performance.
Other devices from Amico Lab, Inc.
Questions
AI-generated answers, 1 Oct 2026
What is the Amizyme Andna Test Kit used for?
The Amizyme Andna Test Kit is designed for the qualitative detection of antinuclear antibodies (ANA) in serum or plasma samples. ANA testing aids in diagnosing autoimmune diseases, such as systemic lupus erythematosus (SLE) and other connective tissue disorders. The kit uses enzyme-labeled antigens to produce a measurable colorimetric reaction, enabling trained laboratory personnel to interpret results for clinical decision-making.
Is the Amizyme Andna Test Kit single-use or reusable?
The Amizyme Andna Test Kit is supplied as a single-use diagnostic reagent. This design ensures consistency and reliability in test results while minimizing the risk of cross-contamination between samples. Each kit is intended for one-time use in a clinical laboratory setting by trained personnel.
What components are included in the Amizyme Andna Test Kit?
The kit includes enzyme-labeled antigens, necessary controls, and all other reagents required to perform the ANA test. These components work together to facilitate the detection of antinuclear antibodies through a standardized colorimetric process. The inclusion of controls helps validate the accuracy and reliability of each test run.
How should the Amizyme Andna Test Kit be stored?
While specific storage conditions and shelf life details are not explicitly provided in the regulatory data, the kit must be handled according to the manufacturer’s instructions to ensure optimal performance. Proper storage typically involves maintaining the kit in a clean, dry environment, protected from extreme temperatures and direct light, until use.
What regulatory clearance does the Amizyme Andna Test Kit hold?
The Amizyme Andna Test Kit holds FDA 510(k) clearance under the classification of Device Class II (866.5100), with the clearance number K842533. This clearance indicates that the device has been deemed substantially equivalent to a legally marketed predicate device, ensuring it meets regulatory standards for safety and effectiveness in clinical laboratory settings.